Member Info for Bobat123

Buys coming in this morning.

Mms surfing for shares all day hope you don’t have stop losses set on this share as low amount in circulation will mean they will be trying there best to get the weak hands out
Gla

Roughly a week to go for the end of the month. Either way will get a rns to advise as to where we are as we have not had a rns since Jan. Dyor.

Peeps can keep selling its up to them.

The company said it is on target to be at a lead stage for programme 4 in the second quarter of the year and to reach pre-clinic stage for programme 3 in the same period.

Interim Chief Executive Officer Clarissa Sowemimo-Coker said: "This was a busy and pivotal period for the company and we are delighted with the progress. The groundwork has been laid for an exciting 2023, with our focus firmly on the commencement of the phase I clinical trial for programme 1. We have worked hard as a team to get to this point which represents a hugely significant milestone for the company and our shareholders."

Programmes Update

Progress towards the commencement of Phase I clinical trial for its lead drug candidate, OCT461201, continues. The trial will commence upon receipt of approval from REC 2 and the MHRA, from which the Company expects to hear shortly.

Meanwhile, OCTP continues to advance its other programmes, with key developments including completion of the pre-clinical work for the Company's second programme OCT130401, which is now ready to enter Phase I. Development work on programmes 3 and 4 has continued and the Company still expects to be at pre-clinical and lead candidate stage for these programmes during Q2 2023. Now that Programme 2 is Phase 1 ready further work will be placed on hold as will work on Programmes 3 and 4 once they have progressed to pre-clinical and lead stage respectively.

Bought In Today.

Also from Rns few weeks ago:
Oxford Cannabinoid Technologies Holdings PLC - cannabinoid medicines-focused pharmaceutical firm - Names Clarissa Sowemimo-Coker as permanent chief executive officer, effective immediately. She was named interim CEO in December, after having joined the firm over four years ago. Additionally, says its subsidiary Oxford Cannabinoid Technologies Ltd has renewed its Home Office licence, which permits OCT to supply Schedule 1 drugs for research purposes. Adds that progress towards the commencement of phase 1 clinical trial for its lead drug candidate, OCT461201, continues.

CEO Sowemimo-Coker says: "I am proud and privileged to be leading the company and our excellent team at such a crucial stage in our development. Our aim is to get our new medicines into the hands of patients who need them as quickly as possible."

MMs taking peeps who are selling to the cleaners.

Very Bullish. Once the 0.85 Barrier is broken there is no stopping the rise.

Lots of resistance from MMS to let this go. Kod with lots of salt and vinegar and Mushy peas please.

The one we wanted to see !

https://twitter.com/KodalMinerals/status/1649008293854040065?s=19

52 Week High 0.84 GONE - Hold on to the Golden Tickets.

52 Week High 0.84 about to go.

MMS not able to hold this down now.

NT to buy now.

Pictures on the tweet just updated minutes ago. Let it roll.

There seems to be force not wanting KOD to rise. After every big buy there is a small sell straightaway. Either that we should see a TR1 on seller.

More buys then sells this morning and MMS managing to hold this down. Bulls still very strong. Steady stable rise coming up. Excellent rns yesterday now slowly will see this moving up.

Hopefully will also see a TR1 on peeps loading up. Stop losses getting hit. They will try everything. GLA

Bulls very strong. Breakout of over 0.8 plus very immiment. Steady stable rise coming up. Excellent rns yesterday now slowly will see this moving up.

We have to remember that the market makers are extremely good at what they do...It is their expertise which makes them rich and keeps us poor. They are playing this share to the limit and I don't blame them, it's what they do.. Play into their hands or sit back, relax and enjoy the swings

We have to remember that the market makers are extremely good at what they do...It is their expertise which makes them rich and keeps us poor. They are playing this share to the limit and I don't blame them, it's what they do.. Play into their hands or sit back, relax and enjoy the swings..